Updated on 14 October 2026
R&D partner
Lead Scientist at AItenea Biotech
Madrid, Spain
About
We work at the intersection of artificial intelligence and chemical synthesis, closing the gap between computational prediction and real-world chemistry , we believe that a promising molecule on paper is only useful if it can actually be synthesized.
Our work cover the following areas:
-
AI-powered software for molecules design and synthesis (Drug discovery, polymeric materials); softwares are validated through the preparation of the molecules in the lab.
-
Drug Discovery focused on CNS, we are now focusing on Alzheimer disease.
-
Process optimization, digital twins applied to industrial reactors, we are developing a platform in collaboration with BASF (Demo in December).
We split our time between proprietary in-house research and partnerships with industrial partners looking to accelerate a discovery program, extend their synthetic chemistry capacity, or integrate an AI layer into an existing pipeline.
I'm at Madrid Connect specifically to explore new partnerships, whether that's a discrete collaboration, a longer-term R&D relationship, or just a conversation with people working on similar problems. If you're in drug discovery, computational chemistry, or biotech innovation, let's talk.
Looking for
- Research
- Joint development
- Business
Attached files
Similar opportunities
Investment
THOR-X: Compact High-Precision Bioprinting for Next-Generation Tissue Engineering
Gianna Arencibia
Head of Research at Omnia Mater SL
Madrid, Spain
Investment
Innovative therapies for chornic liver diseases (NASH)
Alejandro Exposito
CEO at Servatrix Biomed SL
Madrid, Spain